Back to catalogue
№ 437 27 filings · 2021-09-03 → 2026-08-04

XAAR PLC

XAR
Industrial Goods and Services Share price 157p Market cap £132m Overall fit 320 /1000

Interesting differentiated printhead technology with some real emerging exposure to semi/PCB and industrial digitalisation, but the AI-beneficiary angle is peripheral, operating leverage is only moderate, and current valuation demands a material application-ramp that management itself describes as uncertain. Balance sheet is acceptable but earnings quality is weak given repeated adjusting items.

Fair value range 70p–105p Mid case · £69m
Absolute upside -48.1% vs current market cap
Conviction 3/5 confidence in overvalued call
Supports the call
  • Granular divisional disclosure enables sum-of-parts
  • Five-year gross margin and cost base trajectory well documented
  • Net-cash balance sheet and going-concern basis clear
Limits the call
  • Timing of emerging-application ramp materially uncertain per filings
  • Recurring large adjusting items and prior-period restatements muddy 'adjusted' earnings
Methodology

Sum-of-parts (segment aOP x sector multiples) minus head-office drag

In one line · bull case

Genuinely differentiated high-viscosity printhead technology finally converting emerging applications to revenue, but valuation already prices in the ramp management admits is uncertain.

In one line · biggest risk

Emerging applications (Flashforge CJ270, EV battery coating, automotive) slip further, exposing that current market cap is not supported by the small existing profit base.

Drivers
AI beneficiary 32 /100
Semi spin-coat replacement and PCB conformal coating cited but not quantified as material; core exposure is industrial digitalisation not AI picks-and-shovels.
Operating leverage 58 /100
Central/R&D costs relatively fixed but gross margin trajectory (27%->40%) shows scale gains are gradual, not step-change.
Earnings vs expectations 40 /100
Pattern of H2 slippage vs H1 guidance; FY23 profit warning; FY22 and FY25 modest beats vs guidance.
Growth momentum 48 /100
H1 26 revenue +9% cc; printhead new business +96% y/y H1 25 but decelerating; overall Group growth patchy.
Moat 48 /100
Genuine technology differentiation (viscosity capability, TF Technology, ~147 patents) but narrow customer base and modest switching costs at end-user level.
Earnings quality 35 /100
Recurring £1.5m+ half-yearly adjusting items dwarf underlying profit; multiple prior-period restatements.
Management quality 45 /100
New Chair and CFO within 12 months; competent but track record of over-optimistic timing on application launches.
Cyclicality 62 /100
Industrial capex-driven with China ceramics and US EPS both showing cyclical swings.
Leverage 22 /100
Net debt just £0.1m at H1 26 after doubled RCF; low absolute leverage though liquidity has tightened.
Value-trap signals · 6
  • Statutory losses reported every year since 2021 divestment of Xaar 3D
  • Dividend suspended since ~2019 with no clear reinstatement path
  • Legacy ceramics revenue structurally impaired by China property market
  • Recurring restructuring/adjusting items suggest 'clean' earnings are hard to define
  • Historic overseas indirect tax liabilities (~£2.7m) discovered 2025 indicating governance weakness
  • Multiple leadership changes in 2024-2025 (CFO, Chair, EPS management)

XAAR PLC (XAR) — Investment Research Note

Executive summary

Xaar designs and manufactures piezoelectric industrial inkjet printheads with a differentiated ability to jet high-viscosity, high-pigment-loaded fluids that competitors cannot handle. Over the past five years the business has undergone a painful transition away from its legacy ceramic-tile printhead market (structurally impaired by China property weakness) toward new applications — 3D printing (jewellery wax, desktop 3D), EV battery coating, automotive coating, semiconductor spin-coat replacement, PCB conformal coating and textiles — with adjusted profitability finally, if narrowly, restored (FY25 aPBT £0.8m, H1 26 aPBT £0.2m). The single most important valuation issue is that a £92m market cap on <£1m of adjusted PBT prices in a substantial ramp in these emerging applications that the filings themselves describe as materially uncertain in timing.

Fair value estimate

Fair value range: 70p – 105p per share, implying a market cap of £55m – £82m.

Methodology: blended sum-of-parts + forward EV/EBITDA sanity check.

  • Printhead + Megnajet: FY25 aOP £6.5m combined; apply 12-15x on £5-6m sustainable operating profit → £60-90m enterprise value
  • EPS: FY25 aOP £1.3m; apply 8-10x → £10-13m
  • Head-office cost drag: £6m/year at 8x = deduct £48m
  • Add contingent consideration receivable (Xaar 3D earn-out, fair-valued £2.9m at 30 Jun 26)
  • Add net cash of ~£0m (net debt £0.1m at H1 26)

This gives £25-58m equity value from core operations plus £3m contingent = £28-61m base case — well below the current £92m cap. The higher end of my range (£82m) requires meaningfully crediting the new-application pipeline (jewellery wax, Flashforge CJ270, EV battery coating). 2026-08 H1; 2026-03 FY25

vs. current market cap £92.4m: downside c. 5% to 40% depending on where you sit in the range. Midpoint ~87p implies c. 25% downside.

Sector context

Confirmed classification: Industrial Goods and Services — specifically specialist industrial equipment / precision manufacturing. Xaar's quality profile is below typical large-cap peers in this sector: gross margin (~38-40%) is respectable but adjusted operating margin is barely positive; scale is sub-£100m revenue; historical volatility is high. Listed comparable references: Domino Printing (private since 2015 — Brother), Global Graphics (specialist software for print), Videojet (Danaher subsidiary — is a Xaar customer), Kornit Digital (KRNT — textile). Xaar is more properly compared with sub-scale specialist industrials trading on 1-1.5x sales.

Investment thesis

  • Genuinely differentiated technology with annuity aftermarket. Xaar's printheads jet fluids 3x more viscous than the nearest competitor; printheads need replacing every 2-3 years, creating recurring revenue as each new OEM machine populates the installed base. Printhead new business grew 96% H1 25 y/y and 3D Printing & AVM grew 28% in H1 26 2025-08 interim; 2026-08 interim.
  • Multiple long-cycle "wedge" opportunities finally moving to commercialisation. Flashforge CJ270 desktop 3D printer pre-launch orders received, ceramics glaze applications delivering growth, and semiconductor spin-coating replacement + PCB conformal coating cited as delivering revenue. Even one of these scaling would move the group's small profit base materially 2026-08 H1.
  • Balance sheet is defensible. Net debt just £0.1m after doubling the RCF to £10m in March 2026; £29.6m of inventory (some slow-moving) but no covenant issues, going-concern reverse stress test requires >20% revenue drop 2026-03 FY25.

Key risks

  • Valuation is unforgiving. FY25 adjusted EPS of 1.1p implies a P/E north of 100x at 116.5p; the market is already crediting a substantial ramp in new applications whose timing management repeatedly describes as "uncertain" 2026-03 FY25; 2025-08 interim.
  • Track record of adjusting-item creep and governance surprises. Recurring "adjusting items" of £1.5m+ per half (restructuring, FX, share-based, tax provisions) versus £0.2m adjusted profit; £2.7m historic overseas tax liabilities (indirect) discovered in 2025 with penalty contingent liability of £39-460k 2026-08 H1; 2026-03 FY25. This is a business where adjusted numbers materially overstate cash-equivalent performance.
  • Cyclical end-markets and single-customer concentration in emerging apps. Legacy ceramics still declining, EPS division exposed to US capex cycles and tariff drag, key new applications (Flashforge, Axalta/Dürr) depend on single OEM partners. Revenue can move ±10% in a half on customer-launch timing 2025-10 trading update; 2026-08 interim.

Operating leverage

Xaar has meaningful — but not exceptional — operating leverage. Half-year revenue of £29.7m produced £11.5m gross profit (38.7% margin) but only £0.4m adjusted operating profit because central/head-office costs consumed roughly £3.1m in the half and R&D absorbed £2.1m. Gross margin has trended from 27% (2020) → 34% (2021) → 39-40% (2022-25) → 38.7% (H1 26), with management targeting 40%+ as scale returns. On the printhead+Megnajet business specifically, £21m of divisional revenue in H1 26 produced £2.8m of adjusted operating profit — a decremental margin of c. 25% on the £1.4m of incremental revenue vs H1 25 (£19.9m PH revenue → £2.1m PH aOP; H1 26 £21.0m → £2.2m PH aOP). This is respectable but nowhere near "software-like" leverage. A 15-20% revenue beat on the FY25 base would plausibly add £3-4m to operating profit — 3-4x current adjusted PBT, but still not doubling the market cap. The bigger leverage story is if central overhead stays flat while OEM product launches (CJ270, EV battery, automotive) drive step-change revenue 2026-08 H1; 2026-03 FY25.

Value-trap signals

  • Legacy ceramics revenue structurally impaired (down from £15.5m FY24 to £7.5m FY23, then stable at £7.5m FY25 but only recently)
  • Repeated guidance misses in H2 across 2023-24 with tariff/customer-launch slippage
  • Dividend suspended since 2019 with no near-term reinstatement
  • Reported statutory losses every year since divestment of Xaar 3D (FY24 restated loss £10.8m; FY25 loss £3.4m; H1 26 loss £1.8m)
  • Historic indirect tax provision (£2.7m) discovered 2025 indicating governance/compliance weakness
  • Multiple management changes (CFO 2024→2025 rapidly; new Chair Oct 2025; new EPS management 2025)
  • Modest customer concentration risk in emerging applications (Flashforge, Axalta/Dürr partnership)

Earnings vs. expectations

Across the reviewed filings, Xaar has beaten early-year expectations twice (FY22 aPBT £2.8m vs breakeven guidance; FY25 aPBT £0.8m vs modest H1 loss run-rate) and missed materially at least twice (H2 23 significantly weaker than H1 23, driving November 2023 profit warning; FY24 revenue £53.8m from continuing ops well below the growth trajectory implied at the H1 24 interim). Pattern: management is consistently optimistic on medium-term application ramps; near-term delivery is chronically slippery, with H2 typically softer than H1 guidance would suggest. The 2025 result marginally beating January-14-2026 trading-statement expectations was a positive; H1 26 was in line, with FY26 outlook "unchanged" 2026-08 H1; 2026-01 trading update; 2023-11 trading update.

Conviction

Conviction: 3 (moderate).

Anchors: (1) disclosure of divisional revenue/profit is granular enough to sum-of-parts; (2) historic five-year trajectory of gross margin and cost base is well-documented; (3) net-cash balance sheet and going-concern basis unambiguous.

Caveats: (1) valuation is highly sensitive to the pace at which emerging applications (Flashforge CJ270, EV battery coating, automotive coating) actually convert to printhead reorder volumes — the filings acknowledge this is unpredictable; (2) recurring adjusting items and repeated restatements (indirect tax, prior-period contract asset impairments) undermine confidence in reported "adjusted" numbers.

Driver scoring rationale

The AI-beneficiary angle is thin: semiconductor spin-coating replacement and PCB conformal coating are name-checked but neither is quantified as material to the printhead sector split (buried inside "3D Printing & AVM" at £8.6m H1 26). The business is far more an industrial digital-manufacturing story than an AI-picks-and-shovels story. Operating leverage is real but limited by the R&D cost base that scales roughly with revenue. Balance sheet is a strength. Valuation is where this stock scores worst.

Filings consulted · 35

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-08-04Half Year Financial Report2026-08-04_9702398_half-year-financial-report.md0.90
  2. 2026-07-31Investor Presentation Via Investor Meet Company2026-07-31_9698511_investor-presentation-via-investor-meet-company.md0.70
  3. 2026-05-28Result OF Agm2026-05-28_9589710_result-of-agm.md0.30
  4. 2026-04-16Publication OF Annual Report And Notice OF Agm2026-04-16_9523566_publication-of-annual-report-and-notice-of-agm.md0.95
  5. 2026-03-24Final Results2026-03-24_9488160_final-results.md1.00
  6. 2026-03-23Investor Presentation Via Investor Meet Company2026-03-23_9487530_investor-presentation-via-investor-meet-company.md0.70
  7. 2026-01-14Trading Statement2026-01-14_9351697_trading-statement.md0.72
  8. 2025-10-01Trading Update And Notice OF Results2025-10-01_9143804_trading-update-and-notice-of-results.md0.72
  9. 2025-08-122025 Interim Results2025-08-12_9045336_2025-interim-results.md0.58
  10. 2025-07-14Notice OF Interim Results2025-07-14_8977746_notice-of-interim-results.md0.58
  11. 2025-05-28Result OF Agm2025-05-28_8901162_result-of-agm.md0.20
  12. 2025-04-152024 Annual Report And Notice OF Agm2025-04-15_8832616_2024-annual-report-and-notice-of-agm.md0.62
  13. 2025-03-25Final Results2025-03-25_8794831_final-results.md0.65
  14. 2025-01-15Trading Update Amp Notification OF Full Year Results2025-01-15_8688760_trading-update-amp-notification-of-full-year-results.md0.65
  15. 2024-12-112024 Full Year Trading Update2024-12-11_8604509_2024-full-year-trading-update.md0.55
  16. 2024-09-18Interim Results2024-09-18_8422203_interim-results.md0.58
  17. 2024-05-29Result OF Agm2024-05-29_8229029_result-of-agm.md0.14
  18. 2024-03-26Final Results2024-03-26_8106163_final-results.md0.45
  19. 2023-11-29Trading Update2023-11-29_7908874_trading-update.md0.38
  20. 2023-09-192023 Interim Results2023-09-19_7763270_2023-interim-results.md0.41
  21. 2023-09-07Notice OF 2023 Half Year Results2023-09-07_7741418_notice-of-2023-half-year-results.md0.41
  22. 2023-08-03Trading Update2023-08-03_7672737_trading-update.md0.21
  23. 2023-05-31Result OF Agm2023-05-31_7552776_result-of-agm.md0.07
  24. 2023-03-28Final Results2023-03-28_7335739_final-results.md0.25
  25. 2023-03-20Notification OF The 2022 Full Year Results Date2023-03-20_7479343_notification-of-the-2022-full-year-results-date.md0.25
  26. 2023-01-12Trading Update2023-01-12_7396119_trading-update.md0.21
  27. 2022-09-202022 Interim Results2022-09-20_7369422_2022-interim-results.md0.23
  28. 2022-08-30Notice OF 2022 Half Year Results2022-08-30_7106516_notice-of-2022-half-year-results.md0.23
  29. 2022-07-14Trading Update2022-07-14_6994935_trading-update.md0.21
  30. 2022-05-25Result OF Agm2022-05-25_7026462_result-of-agm.md0.07
  31. 2022-03-292021 Full Year Results2022-03-29_7091896_2021-full-year-results.md0.25
  32. 2022-03-03Acquisition OF Megnajet2022-03-03_7014243_acquisition-of-megnajet.md0.19
  33. 2022-01-13Trading Update2022-01-13_6853019_trading-update.md0.21
  34. 2021-09-142021 Interim Results2021-09-14_6825488_2021-interim-results.md0.23
  35. 2021-09-03Notice OF 2021 Interim Results2021-09-03_6719295_notice-of-2021-interim-results.md0.09

This research note was authored by a large language model after reading 27 regulatory filings published between 2021-09-03 and 2026-08-04. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.